Two N.J. sentenced in insider-trading scheme
A former pharmaceutical executive who cooperated with prosecutors was sentenced Thursday to 16 months in prison for his role in an insider-trading ring that made $1.48 million from tips about several health-care companies, including Stryker Corp., which has operations in Mahwah.
Trending on the Topix Network
Christie joins groundbreaking for new building at Celgene in Summit
Governor Christie Wednesday touted Celgene, a maker of cancer drugs, as an example of state government's successfully helping a private company grow.
Gilead: This Baby Has Been Thrown Away With The Bathwater
The Biotech sector has been under severe pressure lately and it seems to make the "headlines" daily as the cause for so much of the NASDAQ weakness.
Tue Apr 15, 2014
Silicon Alley Insider
Here's Data On The 50 Best Employers In America
For our second annual list of the 50 Best Employers in America , Business Insider used data gathered and crunched by PayScale to evaluate companies on pay and happiness.
Mon Apr 14, 2014
Pfizer's Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts
Ian C. Read, chairman and CEO of Pfizer, Inc, was elected chairman of the Pharmaceutical Research and Manufacturers of America today at the trade association's annual meeting.
Celgene Growth Unappreciated In Recent Sell-Off
Celgene Corporation is a top biopharmaceutical company currently involved in researching, developing, and commercializing products for treating chronic diseases such as cancer and other conditions related to immune systems and inflammatory problems.
Hopes pinned on biotech firms' development of novel treatments
When it comes to biotech stocks, patience is the key. Investors need to hold on for the long-term while learning more about how their stocks will become more valuable in the future.
Fri Apr 11, 2014
Pfizer Inc. CEO Takes On Additional Role, Becomes PhRMA Board Chairman
Pfizer's Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts WASHINGTON, Apr 11, 2014 -- Ian C. Read, chairman and CEO of Pfizer, Inc, was elected chairman of the Pharmaceutical Research and Manufacturers of America today at the trade association's annual meeting.
3 Biotech Companies That Look To Be Good Buys After A Pullback
Though the biotech sector may be volatile there are a number of positive reasons that these three stocks should move higher.
Globl orphan drugs market growth dampened by high costs of drug development
One of the key factors contributing to this market growth is the shorter development timelines.
Thu Apr 10, 2014
Small Interest Rises As Biotechs Fall
In a period when many biotech stocks were slipping, short sellers moved on many of the leading biotech and emerging pharmaceuticals between the March 14 and March 31 settlement dates.
Wed Apr 09, 2014
BlackBerry CEO May Consider Exiting Handset Business; Celgene...
Shares of Merck & Co. closed up 3.74% on Wednesday with about 16 million shares traded.
Drug-merger insider trading scheme ends in jail for 2 NJ men
A federal judge on Wednesday ordered two New Jersey men to serve prison time for their admitted roles in a $1.48 million insider-trading scheme involving medical, technical and pharmaceutical companies.
Wednesday Sector Leaders: Materials, Healthcare
The best performing sector as of midday Wednesday is the Materials sector, up 1.5%.
Celgene Higher on Revlimid Patent Case Document Release
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Tue Apr 08, 2014
Edge Therapeutics Expands Senior Management Team and Opens New...
Edge Therapeutics, a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions, today announced the appointment and promotion of key executives to its senior management team ... (more)
Mon Apr 07, 2014
Celgene In Mylan's Cross-Hairs: "I'm Shakin' In My Boots"... Well, Maybe A Little
Mylan's actions are understandable, but success is questionable given its "litigious" history and the very nature of the business model.
Sun Apr 06, 2014
Celgene Corporation Sued by Mylan Inc.; GRUBHUB Soars on its First...
GRUBHUB closed up 30.77% on nearly 11 million shares traded this past Friday, making it one of the biggest gainers on the NYSE.
Fri Apr 04, 2014
BetterInvesting Magazine Releases June Stock To Study And Undervalued ...
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Skyworks Solutions, Inc. as its June 2014 "Stock to Study" and Celgene Corporation as its June 2014 "Undervalued Stock" for investors' informational and educational use.
Who Says There's No Biotech Bubble?
Biotech stocks are plunging today, which once again raises the question: Are we witnessing the popping of the biotech bubble ? It's hard not to think it might be.